The association of EGF rs2237051 variant, serum EGF levels and generalized aggressive periodontitis: a preliminary study

Background Epidermal growth factor (EGF) is a pro-inflammatory small peptide that stimulates cell growth, proliferation and differentiation through binding to its receptor. EGF rs2237051 and serum EGF levels have been demonstrated to be related with a variety of diseases, including several tumors an...

Full description

Bibliographic Details
Main Authors: Xian’e Wang, Wenjing Li, Li Xu, Ruifang Lu, Huanxin Meng
Format: Article
Language:English
Published: PeerJ Inc. 2020-05-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/9212.pdf
_version_ 1797422179613147136
author Xian’e Wang
Wenjing Li
Li Xu
Ruifang Lu
Huanxin Meng
author_facet Xian’e Wang
Wenjing Li
Li Xu
Ruifang Lu
Huanxin Meng
author_sort Xian’e Wang
collection DOAJ
description Background Epidermal growth factor (EGF) is a pro-inflammatory small peptide that stimulates cell growth, proliferation and differentiation through binding to its receptor. EGF rs2237051 and serum EGF levels have been demonstrated to be related with a variety of diseases, including several tumors and inflammatory diseases. Therefore, this study aims to investigate the association of the EGF rs2237051 variant and serum EGF levels in Chinese patients with generalized aggressive periodontitis (GAgP). Material and Methods A case-control study was conducted among 216 patients with GAgP and 138 healthy controls. The clinical parameters of plaque index, probing depth, attachment loss and bleeding index were recorded. The EGF rs2237051 polymorphism was genotyped using time-of-flight mass spectrometry, and serum EGF levels were determined. Logistic and linear regression models were used to investigate the association between the genotypes of EGF rs2237051, serum EGF levels and GAgP risk. Results The AA genotype of EGF rs2237051 showed higher risk for GAgP than the combined genotypes GG and AG (adjusted OR = 1.65, 95% CI [1.06–2.57]). Increased serum EGF levels were associated with GAgP (adjusted OR = 1.18, 95% CI [1.14–1.22]). Moreover, the serum EGF level for the AA genotype was significantly higher than that for the AG/GG genotypes in patients with GAgP (adjusted β = 4.70, 95% CI [2.09–7.31]). Conclusion We demonstrated that EGF rs2237051 variant and the increased level of serum EGF were associated with the risk of GAgP, the serum EGF was up-regulated in patients with GAgP. It was indicated that serum EGF might be a biomarker of GAgP and EGF rs2237051 may be related to the genetic background of GAgP.
first_indexed 2024-03-09T07:29:29Z
format Article
id doaj.art-a3b27d1a807a4a7e9f6562c71be68bea
institution Directory Open Access Journal
issn 2167-8359
language English
last_indexed 2024-03-09T07:29:29Z
publishDate 2020-05-01
publisher PeerJ Inc.
record_format Article
series PeerJ
spelling doaj.art-a3b27d1a807a4a7e9f6562c71be68bea2023-12-03T06:47:10ZengPeerJ Inc.PeerJ2167-83592020-05-018e921210.7717/peerj.9212The association of EGF rs2237051 variant, serum EGF levels and generalized aggressive periodontitis: a preliminary studyXian’e WangWenjing LiLi XuRuifang LuHuanxin MengBackground Epidermal growth factor (EGF) is a pro-inflammatory small peptide that stimulates cell growth, proliferation and differentiation through binding to its receptor. EGF rs2237051 and serum EGF levels have been demonstrated to be related with a variety of diseases, including several tumors and inflammatory diseases. Therefore, this study aims to investigate the association of the EGF rs2237051 variant and serum EGF levels in Chinese patients with generalized aggressive periodontitis (GAgP). Material and Methods A case-control study was conducted among 216 patients with GAgP and 138 healthy controls. The clinical parameters of plaque index, probing depth, attachment loss and bleeding index were recorded. The EGF rs2237051 polymorphism was genotyped using time-of-flight mass spectrometry, and serum EGF levels were determined. Logistic and linear regression models were used to investigate the association between the genotypes of EGF rs2237051, serum EGF levels and GAgP risk. Results The AA genotype of EGF rs2237051 showed higher risk for GAgP than the combined genotypes GG and AG (adjusted OR = 1.65, 95% CI [1.06–2.57]). Increased serum EGF levels were associated with GAgP (adjusted OR = 1.18, 95% CI [1.14–1.22]). Moreover, the serum EGF level for the AA genotype was significantly higher than that for the AG/GG genotypes in patients with GAgP (adjusted β = 4.70, 95% CI [2.09–7.31]). Conclusion We demonstrated that EGF rs2237051 variant and the increased level of serum EGF were associated with the risk of GAgP, the serum EGF was up-regulated in patients with GAgP. It was indicated that serum EGF might be a biomarker of GAgP and EGF rs2237051 may be related to the genetic background of GAgP.https://peerj.com/articles/9212.pdfAggressive periodontitisEpidermal growth factorGenetics
spellingShingle Xian’e Wang
Wenjing Li
Li Xu
Ruifang Lu
Huanxin Meng
The association of EGF rs2237051 variant, serum EGF levels and generalized aggressive periodontitis: a preliminary study
PeerJ
Aggressive periodontitis
Epidermal growth factor
Genetics
title The association of EGF rs2237051 variant, serum EGF levels and generalized aggressive periodontitis: a preliminary study
title_full The association of EGF rs2237051 variant, serum EGF levels and generalized aggressive periodontitis: a preliminary study
title_fullStr The association of EGF rs2237051 variant, serum EGF levels and generalized aggressive periodontitis: a preliminary study
title_full_unstemmed The association of EGF rs2237051 variant, serum EGF levels and generalized aggressive periodontitis: a preliminary study
title_short The association of EGF rs2237051 variant, serum EGF levels and generalized aggressive periodontitis: a preliminary study
title_sort association of egf rs2237051 variant serum egf levels and generalized aggressive periodontitis a preliminary study
topic Aggressive periodontitis
Epidermal growth factor
Genetics
url https://peerj.com/articles/9212.pdf
work_keys_str_mv AT xianewang theassociationofegfrs2237051variantserumegflevelsandgeneralizedaggressiveperiodontitisapreliminarystudy
AT wenjingli theassociationofegfrs2237051variantserumegflevelsandgeneralizedaggressiveperiodontitisapreliminarystudy
AT lixu theassociationofegfrs2237051variantserumegflevelsandgeneralizedaggressiveperiodontitisapreliminarystudy
AT ruifanglu theassociationofegfrs2237051variantserumegflevelsandgeneralizedaggressiveperiodontitisapreliminarystudy
AT huanxinmeng theassociationofegfrs2237051variantserumegflevelsandgeneralizedaggressiveperiodontitisapreliminarystudy
AT xianewang associationofegfrs2237051variantserumegflevelsandgeneralizedaggressiveperiodontitisapreliminarystudy
AT wenjingli associationofegfrs2237051variantserumegflevelsandgeneralizedaggressiveperiodontitisapreliminarystudy
AT lixu associationofegfrs2237051variantserumegflevelsandgeneralizedaggressiveperiodontitisapreliminarystudy
AT ruifanglu associationofegfrs2237051variantserumegflevelsandgeneralizedaggressiveperiodontitisapreliminarystudy
AT huanxinmeng associationofegfrs2237051variantserumegflevelsandgeneralizedaggressiveperiodontitisapreliminarystudy